Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes

Figure 4

% change in urinary concentrations of Alb normalized by urinary concentrations of creatinine (UAlbCR) defined by the cutoff value of urinary concentrations of angiotensinogen normalized by urinary concentrations of creatinine (UAGTCR) before treatment. When all patients were redivided into two groups, those with higher UAGTCR levels before treatment (Group H, ) and those with lower levels (Group L), % change in UAlbCR was significantly lower in Group H than in Group L (% versus %, ).